Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 3

Results: 14

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00645-1

By:

Bazarbachi, Abdul Hamid;
Al Hamed, Rama;
Malard, Florent;
Bazarbachi, Ali;
Harousseau, Jean-Luc;
Mohty, Mohamad

Publication type:

Article

Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21<sup>R110</sup> chronic lymphocytic leukemia.

Published in:

2022

By:

Paschold, Lisa;
Simnica, Donjete;
Brito, Ramon Benitez;
Zhang, Tianjiao;
Schultheiß, Christoph;
Dierks, Christine;
Binder, Mascha

Publication type:

Letter

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication.

Published in:

2022

By:

Huo, Yu-Jia;
Xu, Peng-Peng;
Fu, Di;
Yi, Hong-Mei;
Huang, Yao-Hui;
Wang, Li;
Wang, Nan;
Ji, Meng-Meng;
Liu, Qing-Xiao;
Shi, Qing;
Wang, Shuo;
Cheng, Shu;
Feng, Yan;
Zhao, Wei-Li

Publication type:

Letter

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00637-1

By:

Durmaz, Müjde;
Visser, Otto;
Posthuma, Eduardus F. M.;
Brouwer, Rolf E.;
Issa, Djamila E.;
de Jong, Daphne;
Lam, King H.;
Blijlevens, Nicole M. A.;
Zijlstra, Josée M.;
Chamuleau, Martine E. D.;
Lugtenburg, Pieternella J.;
Kersten, Marie José;
Dinmohamed, Avinash G.

Publication type:

Article

Clonal hematopoiesis in primary immune thrombocytopenia.

Published in:

2022

By:

Wang, Yanming;
Yu, Tianshu;
Dong, Qiaofeng;
Liu, Shuang;
Yu, Yafei;
Zhao, Hong Yu;
Ma, Ji;
Dong, Lin;
Wang, Liang;
Ma, Daoxin;
Zhao, Yajing;
Hou, Yu;
Liu, Xinguang;
Peng, Jun;
Hou, Ming

Publication type:

Letter

Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.

Published in:

2022

By:

Brink, Mirian;
Minnema, Monique C.;
Visser, Otto;
Levin, Mark-David;
Posthuma, Eduardus F. M. Ward;
Broijl, Annemiek;
Sonneveld, Pieter;
van der Klift, Marjolein;
Roeloffzen, Wilfried W. H.;
Westerman, Matthijs;
van Rooijen, Cleo R.;
Geerts, Paul A. F.;
Zweegman, Sonja;
van de Donk, Niels W. C. J.;
Dinmohamed, Avinash G.

Publication type:

Letter

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00639-z

By:

Gangat, Naseema;
Jadoon, Yamna;
Szuber, Natasha;
Hanson, Curtis A.;
Wolanskyj-Spinner, Alexandra P.;
Ketterling, Rhett P.;
Pardanani, Animesh;
Tefferi, Ayalew

Publication type:

Article

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00638-0

By:

Atrash, Shebli;
Flahavan, Evelyn M.;
Xu, Tao;
Ma, Esprit;
Karve, Sudeep;
Hong, Wan-Jen;
Jirau-Lucca, Gilbert;
Nixon, Michael;
Ailawadhi, Sikander

Publication type:

Article

Extramedullary disease in multiple myeloma: a systematic literature review.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00643-3

By:

Bladé, Joan;
Beksac, Meral;
Caers, Jo;
Jurczyszyn, Artur;
von Lilienfeld-Toal, Marie;
Moreau, Philippe;
Rasche, Leo;
Rosiñol, Laura;
Usmani, Saad Z.;
Zamagni, Elena;
Richardson, Paul

Publication type:

Article

secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00636-2

By:

Kumar, Harish;
Mazumder, Suman;
Chakravarti, Sayak;
Sharma, Neeraj;
Mukherjee, Ujjal Kumar;
Kumar, Shaji;
Baughn, Linda B;
Van Ness, Brian G;
Mitra, Amit Kumar

Publication type:

Article

Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00631-7

By:

Langendonk, Myra;
de Jong, Mathilde R. W.;
Smit, Nienke;
Seiler, Jonas;
Reitsma, Bart;
Ammatuna, Emanuele;
Glaudemans, Andor W. J. M.;
van den Berg, Anke;
Huls, Gerwin A.;
Visser, Lydia;
van Meerten, Tom

Publication type:

Article

Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2<sup>V617F</sup>-induced myeloproliferative neoplasms.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00628-2

By:

Hu, Mengshi;
Yang, Tao;
Yang, Linyu;
Niu, Lu;
Zhu, Jinbing;
Zhao, Ailin;
Shi, Mingsong;
Yuan, Xue;
Tang, Minghai;
Yang, Jianhong;
Pei, Heying;
Yang, Zhuang;
Chen, Qiang;
Ye, Haoyu;
Niu, Ting;
Chen, Lijuan

Publication type:

Article

Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.

Published in:

2022

By:

Chen, Nianci;
Xu, Yingxi;
Mou, Junli;
Rao, Qing;
Xing, Haiyan;
Tian, Zheng;
Tang, Kejing;
Wang, Min;
Wang, Jianxiang

Publication type:

Correction Notice

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00623-7

By:

Griffen, Ti'ara L.;
Hoff, Fieke W.;
Qiu, Yihua;
Lillard Jr., James W.;
Ferrajoli, Alessandra;
Thompson, Philip;
Toro, Endurance;
Ruiz, Kevin;
Burger, Jan;
Wierda, William;
Kornblau, Steven M.

Publication type:

Article